대한핵의학회지 (1967년~2009년)
Nucl Med Mol Imaging 2008;42(6)464~468
I-131 치료를 받은 분화갑상선암 환자에서 I-131의 유효반감기
(Effective Half-life of I-131 in Patients with Differentiated Thyroid Cancer Treated by Radioactive I-131)
Author 박석건,
Seok Gun Park
Affiliation 단국대학교의과대학 핵의학교실
Nuclear Medicine Department, College of Medicine, Dankook University, Cheonan, Korea
Abstract

Purpose: Effective half life of I-131 (Teff) in patients with differentiated thyroid cancer treated by I-131 is must-know value for dose calculation and determination of release time from isolation room. There has been no report about Teff in Koreans. Thus, author tried to measure dose rate without radiation exposure to faculty members and calculated Teff. Methods: Probe of radiation survey meter was fixed at the wall of isolation room, and body of survey meter was placed outside the room. With this simple arrangement, author could measure radiation frequently without radiation exposure to faculty members in 68 patient (F=55, M=13, age=47±13.7) treated by I-131 (3.7∼7.4 GBq) for differentiated thyroid cancer from Jan 2006 to Dec 2006. From this data, Teff, 48 hr retention rate, and the time necessary to whole body retention of I-131 become less than 1.1 GBq were calculated. Serum creatinine levels were measured before and after thyroid hormone withdrawal. Results: Teff was 15.4±4.3 hr (9.4∼32.5 hr). There was a loose correlation between Teff and serum creatinine concentration (r=0.45). 48hr retention was 4.9±4.2% (1∼23%). Time necessary to whole body retention of I-131 become less than 1.1 GBq was calculated as 47.1±13.2 hr for 9.25 GBq, 42.1±11.9 hr for 7.4 GBq, 35.7±10.0 hr for 5.55 GBq, and 26.7±7.5 hr for 3.7 GBq dose of I-131. Conclusion: Author successfully measured radiation dose rates in isolated patients treated by high dose of I-131 without radiation exposure to the faculty members with simple arrangement of survey meter probe. Using those data, Teff and some other indices were calculated. (Nucl Med Mol Imaging 2008;42(6):464-468)

Keyword Thyroid cancer, radioactive iodine, effective half life, dosimetry
Full text Article 420607.pdf 420607.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)